Fig. 10
From: Baclofen-associated neurophysiologic target engagement across species in fragile X syndrome
Effect of acute single-dose RBAC on resting-state EEG in FXS participants (n = 17). Pairs of boxplots visualizing standardized changes in relative power associated with either baclofen (white bars) or placebo (black bars) acute dose challenge across cortical region and grouped by frequency band. Significant differences (least-squared means contrasts) between baclofen and placebo treatment effects are designated with asterisks above each boxplot pair and corrected by a 5% false discovery rate (FDR). Cortical regions: L, left; R, right; F, frontal; T, temporal; P, parietal; O, occipital. Significance of adjusted p values: *, p < .05; **, p < .01, ***, p < .001